英文原著
1. Hayashi F, Ohira T, Okazaki K, Nakano H, Sakai A, Hosoya M, Shimabukuro M, Takahashi A, Kazama J, Yasumura S, Hashimoto S, Kawasaki Y, Kobashi G, Ohto H, Kamiya K, the Fukushima Health Management Survey. Relationship between physical activity/exercise habits and the frequency of new onset of lifestyle-related diseases after the Great East Japan Earthquake among residents in Fukushima: the Fukushima Health Management Survey. J Radiat Res 2021;62 (Supple 1):i29. pubmed2. Hirai H, Okazaki K, Ohira T, Maeda M, Sakai A, Nakano H, Hayashi F, Nagao M, Harigane M, Takahashi A, Ohira H, Kazama JJ, Hosoya M, Yabe H, Suzuki Y, Yasumura S, Ohto H, Kamiya K, Shimabukuro M. Suboptimal diabetic control and psychological burden after the triple disaster, in Japan: the Fukushima Health Management Survey. BMJ Open Diabetes Res Care 2021;9:e002007. pubmed
3. Honda K, Okazaki K, Tanaka K, Kazama JJ, Hashimoto S, Ohira T, Sakai A, Yasumura S, Maeda M, Yabe H, Suzuki Y, Hosoya M, Tahakashi A, Nakano H, Yahashi F, Nagao M, Ohira H, Shimabukuro M, Ohto H, Kamiya K. Evacuation after the Great East Japan Earthquake is an independent factor associated with hyperuricemia: the Fukushima Health Management Survey. Nutr Metab Cardiovasc Dis 2021;31:1177. pubmed
4. Horiuchi S, Shinohara R, Otawa S, Kushima M, Akiyama Y, Ooka T, Kojima R, Yokomichi H, Miyake K, Hirai H, Hashimoto K, Shimabukuro M, Yamagata Z. Influence of maternal active and secondhand smoking during pregnancy on childhood obesity at 3 years of age: A nested case-control study from the Japan Environment and Children’s Study (JECS). Int J Environ Res Public Health 2021:18;12506. pubmed
5. Iso H, Cui R, Takamoto I, Kiyama M, Saito I, Okamura T, Miyamoto Y, Higashiyama A, Kiyohara Y, Ninomiya T, Yamada M, Nakagawa H, Sakurai M, Shimabukuro M, Higa M, Shimamoto K, Saitoh S, Daimon M, Kayama T, Noda M, Ito S, Yokote K, Ito C, Nakao K, Yamauchi T, Kadowaki T. Risk classification for metabolic syndrome and the incidence of cardiovascular disease in Japan with the low prevalence of obesity: a pooled analysis for 10 prospective cohort studies. J Am Heart Assoc 2021;10:e020760. pubmed
6. Iwasaki M, Kudo A. Asahi K, Machii N, Iseki K, Satoh H, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population. Sci Rep 2021:11:716 pubmed
7. Kimura H, Tanaka K, Saito H, Iwasaki T, Oda A, Watanabe S, Kanno M, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association of polypharmacy with kidney disease progression in adults with CKD. Clin J Am Soc Nephrol 2021;16:1797-1804. pubmed
8. Ma E, Ohira T, Yasumura S, Yasumura S, Nakano H, Eguchi E, Miyazaki M, Hosoya M, Sakai A, Takahashi A, Ohira H, Kazama J, Shimabukuro M, Yabe H, Maeda M, Ohto H, Kamiya K. Dietary Patterns and Progression of Impaired Kidney Function in Japanese Adults: A Longitudinal Analysis for the Fukushima Health Management Survey. Nutrients 2021;13:168. pubmed
9. Maimaituxun G, Kusunose K, Yamada H, Fukuda D, Yagi S, Torii Y, Yamada N, Soeki T, Masuzaki H, Sata M, Shimabukuro M. Deleterious effects of epicardial adipose tissue volume on global longitudinal strain in patients with preserved left ventricular ejection fraction. Front Cardiovasc Med 2021;7:607825. pubmed
10. Nakayama Y, Yamaguchi Y, Shinzato Y, Okamoto S, Millman JF, Yamashiro K, Takemoto N, Uema T, Arakaki K, Higa H, Koizumi H, Shimabukuro M, Masuzaki H. Retrospective exploratory analyses on gender differences in determinants for incidence and progression of diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Endocr J 2021:68;655-669. pubmed
11. Pham PT, Fukuda D, Nishimoto S, Kim-Kaneyama JR, Lei XF, Takahashi Y, Sato T, Tanaka K, Suto K, Kawabata Y, Yamaguchi K, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Shimada K, Kanematsu Y, Takagi Y, Shimabukuro M, Setou M, Barber GN, Sata M. STING, a cytosolic DNA sensor, plays a critical role in atherogenesis- A link between innate immunity and chronic inflammation caused by lifestyle-related diseases. Eur Heart J 2021;13:4336-4348. pubmed
12. Saito H, Tanabe H, Kudo A, Machii N, Higa M, Yamaguchi S, Maimaituxun G, Abe K, Takahashi A, Tanaka K, Asahi K, Masuzaki H, Ohira H, Kazama JJ, Shimabukuro M. High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes. Sci Rep 2021;11:11753 pubmed
13. Saito H, Tanaka K, Iwasaki T, Oda A, Watanabe S, Nakazima A, Aoyagi K, Kanno M, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease. Sci Rep 2021;11:1380 pubmed
14. Tanaka, A, Shimabukuro M, Teragawa H, Okada Y, Takamura T, Taguchi I, Toyoda S, Tomiyama H, Ueda S, Higashi Y, Node K. Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo‑controlled, randomized EMBLEM trial. Cardiovasc Diabetol 2021;20:105. pubmed
15. Tanaka, A, Shimabukuro M, Teragawa H, Okada Y, Takamura T, Taguchi I, Toyoda S, Tomiyama H, Ueda S, Higashi Y, Node K. Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin. Cardiovasc Diabetol 2021; 20: 160. pubmed
16. Tanaka K, Saito H, Iwasaki T, Oda A, Watanabe S, Kanno M, Kimura H, Shimabukuro M, Asahi K, Watanabe T, James Kazama J. Status of Anemia According to Underlying Renal Disease in Chronic Kidney Disease: The Fukushima CKD Cohort. Annals Clin Epidemiol 2021;3:27-35. pubmed
17. Tanaka K, Saito H, Iwasaki T, Oda A, Watanabe S, Kanno M, Kimura H, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association between serum potassium levels and adverse outcomes in chronic kidney disease: The Fukushima CKD Cohort study. Clin Exp Nephrol 2021;25:410. pubmed
18. Yamaguchi S, Manabe O, Abe M, Chiba I, Arasaki O, Shimabukuro M. Fractional flow reserve value of reverse redistribution in 201-thallium stress scintigraphy. Vasc Failure 2021;4:46-53. pubmed
19. Watanabe K, Higa M, Hasegawa Y, Kudo A, Allsopp RC, Willcox BJ, Willcox DC, Sata M, Masuzaki H, Shimabukuro M. Regional variations of insulin secretion and insulin sensitivity in Japanese participants with normal glucose tolerance. Front Nutr 2021;8:632422. pubmed
英文総説
1. Millman JF, Okamoto S, Teruya T, Uema T, Ikematsu S, Shimabukuro M, Masuzaki H. Extra virgin olive oil and the gut-brain axis: influence on gut microbiota, mucosal immunity, cardio-metabolic and cognitive health. Nutr Rev in presss pubmed2. Sasaki A, Yokote K, Naitoh T. et al. Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity. Diabetol Int 2021;13:1-30. pubmed
3. Tanabe H, Masuzaki H, Shimabukuro M. Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective. Diabetes Res Clin Pract 2021:180;109067 pubmed
英文症例
・Higa M, Zaha A, Takushi T, Morishima N, Majikina T, Touma T, Shimabukuro M, Masuzaki H, Honda M, Hasegawa T. Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency. Hum Genome Var 2021;8:6 pubmed和文著書
・日本人の肥満2型糖尿病患者に対する減量・代謝改善手術の適応基準に関する3学会合同委員会 日本肥満症治療学会、日本糖尿病学会、日本肥満学会 監修 日本人の肥満2型糖尿病患者に対する減量・代謝改善手術に対するコンセンサスステートメント コンパス出版局 2021年 pubmed ・齋藤悠、島袋 充生 高浸透圧高血糖状態 糖尿病最新の治療 2022-2024 南江堂 2021年 177-180頁
・島袋充生 インスリン療法 内分泌疾患・糖尿病・代謝疾患―診療のエッセンス 日本医師会雑誌 特別号(2) 生涯教育シリーズ 南江堂 2021年
・島袋充生 インスリン療法 内分泌疾患・糖尿病・代謝疾患―診療のエッセンス 日本医師会雑誌 特別号(2) 生涯教育シリーズ 南江堂 2021年
和文総説
・根本雄飛、島袋充生【女性の生活習慣病:新たな展開】体脂肪分布と生活習慣病 Horm Front Gynecol 2021:28:25-32. pubmed
